Back to Journals » Neuropsychiatric Disease and Treatment » Volume 15 » Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study
Please verify you are not a robot.